<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Onco-innovations Ltd. — News on 6ix</title>
    <link>https://6ix.com/company/onco-innovations-ltd-1</link>
    <description>Latest news and press releases for Onco-innovations Ltd. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 05 May 2026 22:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/onco-innovations-ltd-1" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d6af8fbeedb30cb6ff9607.webp</url>
      <title>Onco-innovations Ltd.</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1</link>
    </image>
    <item>
      <title>Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-inka-health-collaborative-research-to-advance-oncology-evidence-generation</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-inka-health-collaborative-research-to-advance-oncology-evidence-generation</guid>
      <pubDate>Tue, 05 May 2026 22:00:00 GMT</pubDate>
      <description>VANCOUVER, BC / ACCESS Newswire / May 5, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) is pleased to announce that Inka Health Corp. (&quot;Inka Health&quot;), the Company&apos;s wholly owned subsidiary, ...</description>
    </item>
    <item>
      <title>Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-expands-manufacturing-scale-up-of-its-pnkp-inhibitor-technology-with-dalton-pharma-services-advancing-multi-kilogram-non-gmp-synthesis-to-support-ind-enabling-studies</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-expands-manufacturing-scale-up-of-its-pnkp-inhibitor-technology-with-dalton-pharma-services-advancing-multi-kilogram-non-gmp-synthesis-to-support-ind-enabling-studies</guid>
      <pubDate>Fri, 01 May 2026 22:00:00 GMT</pubDate>
      <description>Also Announces Extension of IR Program VANCOUVER, BC / ACCESS Newswire / May 1, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H, WKN: A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) is pleased to announce that its manufacturing partner, ...</description>
    </item>
    <item>
      <title>Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-successful-scale-up-of-key-materials-used-in-the-synthesis-of-its-active-pharmaceutical-ingredient-for-its-pnkp-inhibitor-technology-program</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-successful-scale-up-of-key-materials-used-in-the-synthesis-of-its-active-pharmaceutical-ingredient-for-its-pnkp-inhibitor-technology-program</guid>
      <pubDate>Tue, 28 Apr 2026 22:00:00 GMT</pubDate>
      <description>VANCOUVER, BC / ACCESS Newswire / April 28, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) announced, further to its news release dated April 21, 2026, the successful scale-up of key ...</description>
    </item>
    <item>
      <title>Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-advances-polymer-testing-as-it-moves-its-pnkp-inhibitor-technology-toward-ind-enabling-studies</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-advances-polymer-testing-as-it-moves-its-pnkp-inhibitor-technology-toward-ind-enabling-studies</guid>
      <pubDate>Thu, 23 Apr 2026 22:00:00 GMT</pubDate>
      <description>VANCOUVER, BC / ACCESS Newswire / April 23, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) is pleased to announce that it has advanced an analytical method used to measure and control ...</description>
    </item>
    <item>
      <title>Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-completion-of-analytical-method-development-for-monomer-intermediate-1-supporting-onc010-program-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-completion-of-analytical-method-development-for-monomer-intermediate-1-supporting-onc010-program-1</guid>
      <pubDate>Tue, 21 Apr 2026 22:00:00 GMT</pubDate>
      <description>VANCOUVER, BC / ACCESS Newswire / April 21, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) announces the successful completion of a significant milestone with Dalton Pharma Services ...</description>
    </item>
    <item>
      <title>Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-strengthens-executive-leadership-with-appointment-of-dr-islam-mohamed-as-chief-medical-officer-and-stephen-m-novak-as-chief-of-research-and-development-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-strengthens-executive-leadership-with-appointment-of-dr-islam-mohamed-as-chief-medical-officer-and-stephen-m-novak-as-chief-of-research-and-development-1</guid>
      <pubDate>Fri, 17 Apr 2026 23:00:00 GMT</pubDate>
      <description>VANCOUVER, BC / ACCESS Newswire / April 17, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) is pleased to announce the appointments of Dr. Islam Mohamed as Chief Medical Officer (CMO) ...</description>
    </item>
    <item>
      <title>Onconetix Highlights Realbotix&apos;s Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotixs-launch-of-vinci-ai-vision-system-with-delivery-of-first-vinci-equipped-humanoid-robot-to-ericsson-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotixs-launch-of-vinci-ai-vision-system-with-delivery-of-first-vinci-equipped-humanoid-robot-to-ericsson-1</guid>
      <pubDate>Thu, 09 Apr 2026 12:30:00 GMT</pubDate>
      <description>Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; O...</description>
    </item>
    <item>
      <title>Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-executes-engagement-agreement-with-rdi-partners-and-establishes-onco-innovations-au-pty-ltd-to-advance-australian-phase-i-strategy-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-executes-engagement-agreement-with-rdi-partners-and-establishes-onco-innovations-au-pty-ltd-to-advance-australian-phase-i-strategy-1</guid>
      <pubDate>Tue, 07 Apr 2026 22:00:00 GMT</pubDate>
      <description>Company also announces Marketing Engagement VANCOUVER, BC / ACCESS Newswire / April 7, 2026 / Onco-Innovations Limited (CBOECA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) is pleased to announce the execution of an engagement ...</description>
    </item>
    <item>
      <title>Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-45</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-45</guid>
      <pubDate>Thu, 02 Apr 2026 12:30:00 GMT</pubDate>
      <description>Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Pro...</description>
    </item>
    <item>
      <title>OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onemednet-onco-innovations-and-inka-health-announces-collaboration-aimed-to-accelerate-potential-for-oncology-drug-development-using-real-world-data-and-ai-10</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onemednet-onco-innovations-and-inka-health-announces-collaboration-aimed-to-accelerate-potential-for-oncology-drug-development-using-real-world-data-and-ai-10</guid>
      <pubDate>Wed, 01 Apr 2026 12:55:00 GMT</pubDate>
      <description>MINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD), is pleased to announce that Inka Health, a wholly-owned subsidiary of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) has entered into a collaboration with OneMedNet Inc., under which Onco-Innovations and Inka Health will have access to OneM</description>
    </item>
    <item>
      <title>Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-appoints-david-white-as-chief-executive-officer-and-sammy-dorf-as-member-of-the-board-of-directors</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-appoints-david-white-as-chief-executive-officer-and-sammy-dorf-as-member-of-the-board-of-directors</guid>
      <pubDate>Tue, 31 Mar 2026 12:30:00 GMT</pubDate>
      <description>Experienced Leadership Team Positioned to Execute Pending Transformative Acquisition of Realbotix...</description>
    </item>
    <item>
      <title>Onconetix Highlights Realbotix&apos;s Role in Ericsson&apos;s World-First 6G Trial Demonstration</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotixs-role-in-ericssons-world-first-6g-trial-demonstration</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotixs-role-in-ericssons-world-first-6g-trial-demonstration</guid>
      <pubDate>Wed, 25 Mar 2026 16:47:00 GMT</pubDate>
      <description>Realbotix Humanoid Robot &amp;#x2014; Ericsson&amp;#x2019;s First Enterprise Robotics Client &amp;#x2014; Fea...</description>
    </item>
    <item>
      <title>Onconetix, Inc. Announces 1-for-5 Reverse Stock Split</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-1-for-5-reverse-stock-split</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-1-for-5-reverse-stock-split</guid>
      <pubDate>Mon, 23 Mar 2026 12:30:00 GMT</pubDate>
      <description>CINCINNATI, Ohio, March 23, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (&amp;#x201C;Onco...</description>
    </item>
    <item>
      <title>Onco-Innovations Announces Closing of Private Placement</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-closing-of-private-placement-24</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-closing-of-private-placement-24</guid>
      <pubDate>Thu, 12 Mar 2026 21:00:00 GMT</pubDate>
      <description>Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / March 12, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) (&quot;Onco&quot; or the &quot;Company&quot;) ...</description>
    </item>
    <item>
      <title>Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/realbotix-corp-announces-the-sale-of-realbotix-llc-subsidiary-to-a-nasdaq-listed-issuer-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/realbotix-corp-announces-the-sale-of-realbotix-llc-subsidiary-to-a-nasdaq-listed-issuer-1</guid>
      <pubDate>Thu, 12 Feb 2026 13:00:00 GMT</pubDate>
      <description>Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (&amp;#x201C;Realbotix&amp;#x201D; or the ...</description>
    </item>
    <item>
      <title>Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-to-acquire-realbotix-llc-usa-based-ai-powered-humanoid-robotics-company</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-to-acquire-realbotix-llc-usa-based-ai-powered-humanoid-robotics-company</guid>
      <pubDate>Thu, 12 Feb 2026 13:00:00 GMT</pubDate>
      <description>A leading AI and humanoid robotics company has commercially available models designed, built and ...</description>
    </item>
    <item>
      <title>Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-filing-of-preliminary-base-shelf-prospectus</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-filing-of-preliminary-base-shelf-prospectus</guid>
      <pubDate>Wed, 04 Feb 2026 23:00:00 GMT</pubDate>
      <description>VANCOUVER, BC / ACCESS Newswire / February 4, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) announces that it has filed a preliminary base shelf prospectus dated February 3, 2026 (the ...</description>
    </item>
    <item>
      <title>Onco-Innovations Announces Private Placement</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-private-placement-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-announces-private-placement-1</guid>
      <pubDate>Sat, 24 Jan 2026 00:00:00 GMT</pubDate>
      <description>Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / January 23, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) (&quot;Onco&quot; or the &quot;Company&quot;) ...</description>
    </item>
    <item>
      <title>Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-engages-i2i-marketing-group-engagement-for-market-awareness-services</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-engages-i2i-marketing-group-engagement-for-market-awareness-services</guid>
      <pubDate>Wed, 21 Jan 2026 23:00:00 GMT</pubDate>
      <description>VANCOUVER, BC / ACCESS Newswire / January 21, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) (&quot;Onco&quot; or the &quot;Company&quot;) announces that it has engaged i2i Marketing Group, LLC (1107 Key Plaza, Suite 222, Key ...</description>
    </item>
    <item>
      <title>Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-chairs-colorectal-cancer-canada-precision-oncology-forum-generating-roadmaps-for-the-next-era-of-cancer-care-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-innovations-chairs-colorectal-cancer-canada-precision-oncology-forum-generating-roadmaps-for-the-next-era-of-cancer-care-1</guid>
      <pubDate>Tue, 09 Dec 2025 23:00:00 GMT</pubDate>
      <description>VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) (&quot;Onco&quot; or the &quot;Company&quot;) is pleased to announce, further to its news release dated September 12, 2025, the completion ...</description>
    </item>
  </channel>
</rss>